PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy
Seth A. Wander(Harvard University), Joyce M. Slingerland(University of Miami), Jianqin Wei(University of Miami), Nanette H. Bishopric(University of Miami), Chad J. Creighton(Baylor College of Medicine), Feng Hong(University of Miami), Andy J. Minn(Cancer Research Institute), Dekuang Zhao(University of Miami), Tan A. Ince(NewYork–Presbyterian Brooklyn Methodist Hospital), Alexandra H. Besser(Sylvester Comprehensive Cancer Center), Clara Milikowski(University of Miami)
Cited by 58
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k